phenprobamate structure
|
Common Name | phenprobamate | ||
|---|---|---|---|---|
| CAS Number | 673-31-4 | Molecular Weight | 179.216 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 295.5±33.0 °C at 760 mmHg | |
| Molecular Formula | C10H13NO2 | Melting Point | 101-104℃ | |
| MSDS | N/A | Flash Point | 132.5±25.4 °C | |
Use of phenprobamatePhenprobamate (3-Phenylpropyl carbamate; MH 532; Proformiphen) is a widely used, centrally acting skeletal muscle relaxant, with sedative and anticonvulsant effects[1]. |
| Name | 3-phenylpropyl carbamate |
|---|---|
| Synonym | More Synonyms |
| Description | Phenprobamate (3-Phenylpropyl carbamate; MH 532; Proformiphen) is a widely used, centrally acting skeletal muscle relaxant, with sedative and anticonvulsant effects[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 295.5±33.0 °C at 760 mmHg |
| Melting Point | 101-104℃ |
| Molecular Formula | C10H13NO2 |
| Molecular Weight | 179.216 |
| Flash Point | 132.5±25.4 °C |
| Exact Mass | 179.094635 |
| PSA | 52.32000 |
| LogP | 2.16 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.519 |
| InChIKey | CAMYKONBWHRPDD-UHFFFAOYSA-N |
| SMILES | NC(=O)OCCCc1ccccc1 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2924299090 |
|---|
|
~96%
phenprobamate CAS#:673-31-4 |
| Literature: Ichikawa, Yoshiyasu; Morishita, Yukinori; Kusaba, Shuhei; Sakiyama, Naoto; Matsuda, Yasunori; Nakano, Keiji; Kotsuki, Hiyoshizo Synlett, 2010 , # 12 p. 1815 - 1818 |
|
~%
phenprobamate CAS#:673-31-4 |
| Literature: European Journal of Organic Chemistry, , # 5 p. 908 - 911 |
|
~%
phenprobamate CAS#:673-31-4 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 6 p. 2403 - 2410 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
Source: 824
External Id: CYP273
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
Source: NCGC
External Id: HERG01
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
Source: Burnham Center for Chemical Genomics
Target: cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id: SBCCG-A764-CF-PAF-Primary-Assay
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ant...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
Name: Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
Source: NCGC
External Id: APP-Toga-CHIKV-nsp2-p
|
| Quamaquil |
| Extacol |
| Proformiphen |
| Carbamic Acid 3-Phenylpropyl Ester |
| phenprobamate |
| Nelaxan |
| 3-Phenylpropyl carbamate |
| Gamaquil |
| EINECS 211-606-1 |
| MFCD00868163 |
| Eirenal |
| benzenepropanol |
| g-Phenylpropyl Carbamate |
| 3-Phenylpropyl hydrogen carbonimidate |
| Palmita |
| Ansepron |
| Benzenepropanol, carbamate |
| Actiphan |
| Actozine |